Evaluation of Two Toric Soft Contact Lenses After Two Weeks of Wear
Evaluation of Fit and Visual Acuity of the Investigational Toric Lens in Two Phases: Part B: A Dispensing Cross-over Comparison to SofLens66 Toric
1 other identifier
interventional
96
0 countries
N/A
Brief Summary
The purpose of this study is to determine the relative performance of a new toric soft contact lens against a toric contact lens currently available in market, specifically with regards to the comfort and vision after two weeks of use.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Sep 2007
Shorter than P25 for not_applicable
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 1, 2007
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2007
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2007
CompletedFirst Submitted
Initial submission to the registry
December 20, 2007
CompletedFirst Posted
Study publicly available on registry
January 2, 2008
CompletedResults Posted
Study results publicly available
February 19, 2010
CompletedMay 21, 2015
May 1, 2015
3 months
December 20, 2007
August 21, 2009
May 5, 2015
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Subjective Reported Vision
A weighted combined score of one week and two week data calculated from individual vision-related questions asked on a 1-5 scale, 1 = most negative response to 5 = most positive, was used to derive vision outcomes. The analysis shows the outcome for both senofilcon A and alphafilcon A. If score \>0 then greater vision, if \<0 then lesser vision.
1 week
Subject Reported Lens Comfort.
A weighted combined score of one week and two week data calculated from individual comfort-related questions asked on a 1-5 scale, 1=most negative response to 5=most positive response, was used to derive comfort outcomes. The analysis shows the estimates for senofilcon A and alphafilcon A, respectively. Interpretation is \>0 indicates comfortable and \<0 indicates uncomfortable.
1 week
Study Arms (2)
senofilcon A toric / alphafilcon A toric
OTHERsenofilcon A toric contact lenses worn daily during the first period, then alphafilcon A toric contact lenses worn daily during the second period
alphafilcon A toric / senofilcon A toric
OTHERalphafilcon A toric contact lenses worn daily during the first period, then senofilcon A toric contact lenses worn daily during the second period
Interventions
contact lens
contact lens
Eligibility Criteria
You may qualify if:
- be at least 18 and less than or equal to 39 years of age and have a need for vision correction in BOTH eyes (monovision or uniocular fitting is NOT allowed).
- be of Asian descent (Japanese, Chinese, Korean, Polynesian or other Asian ancestry) and have Asian Eye anatomy.
- have successfully worn toric or spherical soft (hydrogel or silicone hydrogel) contact lenses for at least 4-weeks prior to enrollment in the study.
- be able and willing to adhere to the instructions set forth in the protocol.
- agree to wear their contact lenses in both eyes on a daily wear schedule for at least 8 hours per day every day during the study.
- have a distance spherical component between -1.00 D and -5.50 D with cylinder in the range of 0.75 D to 2.25 D and cylinder axis within 10 ° of the vertical and within 20 ° of the horizontal in both eyes
- have a best corrected manifest refraction visual acuity of at least 20/25 or better in each eye.
- be in good general health, based on his/her knowledge.
- read, be given an explanation of, indicate understanding of, and sign the STATEMENT OF INFORMED CONSENT.
You may not qualify if:
- The subject is a rigid gas permeable (RGP) or daily disposable soft lens wearer.
- The presence of clinically significant (grade 3 or 4) anterior segment abnormalities; inflammations such as iritis; or any infection of the eye, lids, or associated structures.
- The presence of ocular or systemic disease or need for medication which might interfere with contact lens wear or which would cause the lenses to be removed more than twice a day. (i.e., Sjögren's syndrome, type II diabetes, etc).
- Slit lamp findings that would contraindicate contact lens wear such as:
- Pathological dry eye or associated findings
- Pterygium or corneal scars within the visual axis
- Neovascularization \>1mm in from the limbus
- History of giant papillary conjunctivitis (GPC) worse than Grade 2
- Anterior uveitis or iritis (past or present)
- Seborrhoeic eczema, seborrhoeic conjunctivitis
- A history of recurrent erosions, corneal infiltrates, corneal ulcer or fungal infections.
- A known history of corneal hypoesthesia (reduced corneal sensitivity.)
- Aphakia, keratoconus or a highly irregular cornea.
- Current pregnancy or lactation (to the best of the subject's knowledge).
- Active participation in another clinical study at any time during this study.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Results Point of Contact
- Title
- Kurt Moody, OD, FAAO
- Organization
- Vistakon
Study Officials
- PRINCIPAL INVESTIGATOR
Jason Chin, O.D.
- PRINCIPAL INVESTIGATOR
James Fujimoto, O.D.
- PRINCIPAL INVESTIGATOR
Weslie Hamada, O.D.
Arthur T. Kobayashi, O.D., Inc.
- PRINCIPAL INVESTIGATOR
Dennis Kuwuabara, O.D.
Eye Care Associates of Hawaii
- PRINCIPAL INVESTIGATOR
Mark Nakano, O.D.
Mark E. Nakano Optometric Corp.
- PRINCIPAL INVESTIGATOR
Ikuko Sugimoto, O.D.
Unaffilliated
- PRINCIPAL INVESTIGATOR
Kevin Rosin, O.D.
Drs. Farkas, Kassalow, Resnick & Associates
- PRINCIPAL INVESTIGATOR
Jennifer Kao, O.D.
Publication Agreements
- PI is Sponsor Employee
- No
- Restriction Type
- OTHER
- Restrictive Agreement
- Yes
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- TREATMENT
- Intervention Model
- CROSSOVER
- Sponsor Type
- INDUSTRY
Study Record Dates
First Submitted
December 20, 2007
First Posted
January 2, 2008
Study Start
September 1, 2007
Primary Completion
December 1, 2007
Study Completion
December 1, 2007
Last Updated
May 21, 2015
Results First Posted
February 19, 2010
Record last verified: 2015-05